KPIs & Operating Metrics(New)
Growth Metrics

Charles River Laboratories International (CRL) Change in Receivables (2016 - 2025)

Charles River Laboratories International has reported Change in Receivables over the past 17 years, most recently at -$27.6 million for Q4 2025.

  • For Q4 2025, Change in Receivables fell 734.27% year-over-year to -$27.6 million; the TTM value through Dec 2025 reached -$35.7 million, down 65.36%, while the annual FY2025 figure was -$35.7 million, 65.36% down from the prior year.
  • Change in Receivables for Q4 2025 was -$27.6 million at Charles River Laboratories International, down from -$26.6 million in the prior quarter.
  • Over five years, Change in Receivables peaked at $59.7 million in Q2 2022 and troughed at -$27.6 million in Q4 2025.
  • A 5-year average of $7.7 million and a median of $3.8 million in 2021 define the central range for Change in Receivables.
  • Biggest five-year swings in Change in Receivables: skyrocketed 1135.05% in 2022 and later crashed 734.27% in 2025.
  • Year by year, Change in Receivables stood at -$9.0 million in 2021, then tumbled by 163.41% to -$23.6 million in 2022, then dropped by 8.68% to -$25.6 million in 2023, then surged by 87.09% to -$3.3 million in 2024, then crashed by 734.27% to -$27.6 million in 2025.
  • Business Quant data shows Change in Receivables for CRL at -$27.6 million in Q4 2025, -$26.6 million in Q3 2025, and -$10.9 million in Q2 2025.